|
2025
|
Invention
|
Doses and formulations of anti-il-15 antibody for the treatment of immune diseases. Described mon... |
|
|
Invention
|
Use of rapamycin for improved antibody production. Disclosed herein are fed-batch methods of prod... |
|
|
Invention
|
Anti-tl1a antibodies for the treatment of ulcerative colitis and crohn's disease.
Methods are pr... |
|
|
Invention
|
Anti-tl1a antibody formulations.
Pharmaceutical formulations comprising an antibody or antigen-b... |
|
|
Invention
|
Chemical dehydration and suspension delivery of protein drug products. Disclosed herein are proce... |
|
2024
|
Invention
|
Uses for attenuated il-2 immunoconjugates. Disclosed herein are methods of treating a cancer in a... |
|
|
Invention
|
Uses for attenuated il-2 immunoconjugates.
Disclosed herein are methods of treating a cancer in ... |
|
|
Invention
|
Antibodies that specifically bind to tl1a and methods of treating skin disease.
Recombinantly ex... |
|
|
Invention
|
Anti-trka antibodies and uses thereof. Disclosed herein are anti-TrkA antibodies, or antigen-bind... |
|
|
Invention
|
Anti-trka antibodies and uses thereof.
Disclosed herein are anti-TrkA antibodies, or antigen-bin... |
|
|
Invention
|
1,4-substituted piperidine derivatives.
Described herein are 1,4-substituted piperidine compound... |
|
|
Invention
|
Anti-pd-1 antibody-attenuated il-2 immunoconjugates and uses thereof. Disclosed herein are modifi... |
|
|
Invention
|
Anti-cxcr2 antibodies and uses thereof.
Disclosed herein are human antibody molecules that immun... |
|
|
Invention
|
Compositions and methods for anti-pacap igg4 antibodies. Pituitary adenylate cyclase-activating p... |
|
2023
|
Invention
|
Substituted 4-benzyl and 4-benzoyl piperidine derivates. Described herein are 1,4-substituted pip... |
|
|
Invention
|
Spiropiperidine derivatives. Described herein are spiropiperidine compounds according to Formula ... |
|
|
Invention
|
Compositions and methods for increasing transport into the brain. The present disclosure generall... |
|
|
Invention
|
Compositions and methods for increasing transport into the brain.
The present disclosure general... |
|
|
Invention
|
Cd38-binding fusion protein combination therapy. Provided herein are methods of treating cancer (... |
|
|
Invention
|
Anti-tl1a antibody formulations. Pharmaceutical formulations comprising an antibody or antigen-bi... |
|
|
Invention
|
Anti-tl1a antibodies for the treatment of ulcerative colitis and crohn's disease. Methods are pro... |
|
|
Invention
|
Anti-par-2 antibodies and methods of use thereof. The present disclosure provides antibodies and ... |
|
|
Invention
|
Anti-pd-1 antibody-attenuated il-2 immunoconjugates and uses thereof.
Disclosed herein are modif... |
|
|
Invention
|
1,4-substituted piperidine derivatives. Described herein are 1,4-substituted piperidine compounds... |
|
|
Invention
|
Anti-cd38 fusion protein formulation. Disclosed herein are compositions comprising a CD38-binding... |
|
|
Invention
|
Antibodies that specifically bind to tl1a and methods of treating gastrointestinal or lung diseas... |
|
|
P/S
|
Pharmaceutical preparations used for the treatment of cancer |
|
2022
|
Invention
|
Cation exchange chromatography wash buffer.
A wash buffer comprising a surfactant for use in aff... |
|
|
Invention
|
Compositions and methods for anti-pacap antibodies. The present disclosure generally relates to a... |
|
|
Invention
|
Anti-cxcr2 antibodies and uses thereof. Disclosed herein are human antibody molecules that immuno... |
|
|
Invention
|
Polynucleotides encoding antibodies that specifically bind to human il-15. Recombinant antibodies... |
|
2021
|
Invention
|
Antibodies that specifically bind to tl1a and methods of treating gastrointestinal disease. Recom... |
|
|
Invention
|
Anti-il-5 antibodies.
Disclosed herein are fully human antibody molecules that immunospecificall... |
|
|
Invention
|
Pharmaceutical prodrugs and methods of their preparation and use.
The disclosure provides compou... |
|
2019
|
Invention
|
Bendamustine pharmaceutical compositions.
The present invention provides pharmaceutical formulat... |
|
|
P/S
|
Educational services, namely, conducting classes and seminars in the field of oncological disease... |
|
2018
|
P/S
|
Pharmaceutical preparations for the treatment of inflammatory disorders, namely, asthma. |
|
|
Invention
|
Antibodies that specifically bind to tl1a and methods of treating respiratory tract diseases. Rec... |
|
|
Invention
|
Treatment strategy for non-responders to 100mg subcutaneous mepolizumab. Disclosed herein are met... |
|
|
Invention
|
Solid forms of bendamustine hydrochloride. Novel solid forms of bendamustine hydrochloride are de... |
|
|
Invention
|
Cation exchange chromatography wash buffer. A wash buffer comprising a surfactant for use in affi... |
|
2017
|
Invention
|
Antibodies that specifically bind to human il-15 and uses thereof. Recombinant antibodies that sp... |
|
|
Invention
|
Pharmaceutical prodrugs and methods of their preparation and use.
X—Y—Z (I).
|
|
2016
|
Invention
|
Substituted 4-benzyl and 4-benzoyl piperidine derivatives. Described herein are 1,4-substituted p... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of inflammatory disorders. |
|
2013
|
P/S
|
Pamphlets and brochures containing information regarding the treatment of cancer |
|
|
P/S
|
Pharmaceutical preparations for the treatment of pain. |
|
2011
|
P/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
2009
|
P/S
|
Chemicals used in industry, science and photography, as well as in agriculture, horticulture and ... |
|
2008
|
P/S
|
Biological preparations and pharmaceutical preparations, all for the treatment of inflammatory di... |
|
2006
|
P/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
|
|
P/S
|
pharmaceuticals, biopharmaceuticals, and specialty pharmaceuticals for the treatment of central n... |
|
|
P/S
|
Pharmaceuticals. Pharmaceutical and biotechnology research and development services, namely devel... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of human sleep disorders. |
|
2005
|
P/S
|
Pharmaceuticals to treat cancer[, and proliferative disorders] [Pharmaceutical and biotechnology ... |
|
2004
|
P/S
|
Pharmaceutical and biotechnology research and development services and commercialization of pharm... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
|
P/S
|
Pharmaceutical and biotechnology research and development services, namely developing diagnostic ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer |
|
2002
|
P/S
|
Pharmaceutical preparation for the treatment of neurological disorders. Providing information by ... |
|
2001
|
P/S
|
Pharmaceutical preparations. Printed matter, namely catalogues, pamphlets, books, manuals, statio... |
|
2000
|
P/S
|
Pharmaceutical preparations (expressly excluding pharmaceutical products for veterinary use, food... |
|
|
P/S
|
Pharmaceutical preparations used for the treatment of cancer. |
|
1998
|
P/S
|
Biotechnology research and development services, namely, developing diagnostic and therapeutic ag... |
|
|
P/S
|
Biopharmaceutical research and development services, namely developing for others diagnostic and ... |
|
1997
|
P/S
|
Biopharmaceutical research and development services namely, developing for others diagnostic and ... |
|
|
P/S
|
Pharmaceutical for the treatment and management of patients with narcolepsy, idiopathic hypersomn... |
|
|
P/S
|
Providing information by means of a global computer network regarding research and development, b... |
|
1996
|
P/S
|
pharmaceutical preparation for the treatment of neurological disorders |
|
1990
|
P/S
|
Biotechnology research and development services, namely developing diagnostic and therapeutic age... |
